IVIg Study: Chronic ITP

Title: A Prospective, Nonrandomized, Open Label, Single Arm, Multicenter, Phase
3 Clinical Study to Evaluate the Efficacy and Safety of Human Normal
Immunoglobulin for Intravenous Administration in Adult Patients with
Chronic Primary Immune Thrombocytopenia.